Page last updated: 2024-08-22

trimetazidine and Carcinoma, Anaplastic

trimetazidine has been researched along with Carcinoma, Anaplastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Abdeljalil, SM; Elghazaly, H; Tolba, MF; Wahdan, SA1
Aboslema, RF; El-Sayed, NM; Elsayed, M; Hazem, RM; Kishk, SM; Mehanna, ET1

Other Studies

2 other study(ies) available for trimetazidine and Carcinoma, Anaplastic

ArticleYear
Insights into the therapeutic outcomes of trimetazidine/doxorubicin combination in Ehrlich solid-phase carcinoma mouse tumor model.
    Life sciences, 2023, Sep-01, Volume: 328

    Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Doxorubicin; Female; Humans; Mice; Treatment Outcome; Trimetazidine

2023
Antitumor effect of trimetazidine in a model of solid Ehrlich carcinoma is mediated by inhibition of glycolytic pathway and AKT signaling.
    Chemico-biological interactions, 2023, Sep-25, Volume: 383

    Topics: Animals; Carcinoma; Mice; Molecular Docking Simulation; Proto-Oncogene Proteins c-akt; Trimetazidine; Tumor Suppressor Protein p53

2023